Please login to the form below

Not currently logged in
Email:
Password:

NICE recommends BMS and Pfizer’s Eliquis for blood clots

Eliquis BMS PfizerWill be a treatment option for venous thromboembolism

Merck and Eisai link up on anti-PD-1 combinations

Will test Keytruda with both Lenvima and Halaven

Opdivo gains new US lung cancer licence

Bristol-Myers Squibb (BMS) buildingAdds to Bristol-Myers Squibb’s therapeutic vaccine’s melanoma indication

Eurocom Healthcare Communications expands to Turkey

Ixir Healthcare Communications joins alliance

Digital health charge led by millennials in the US

Apple WatchBut older patients more likely to use pharma sites if directed by a doctor

Campaigns improve cancer symptom awareness, claims BJC

Has shown an increase in GP visits for possible cancer symptoms

AbbVie to acquire cancer biopharma Pharmacyclics for $21bn

Humira - AbbottComes six months after the US firm pulled out of a $54bn deal with Shire

Nikon expands into healthcare and buys retinal tech firm

Japanese camera and technology company spends big on Scotland’s Optos

darwins medicineDoes 'trust leadership' feature in your strategy?

Pharma companies wanting to be more patient-focused will need to develop their people skills

Latest appointments

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CreateHealth.io

We connect companies to customers through online and offline events. Our proprietary customer insight platform, and expert staff in stakeholder...

Latest intelligence

blog-icon_build_your_argumentation.png
Build your e-detailing argumentation
We’ve written a number of posts recently giving insights into the Anthill method for structuring e-detailing & CLM presentations. To help you overview, we’ve put these argumentation posts together....
Growing influence of pharmacists in the sale of Rx and OTC medicines
Find out how the changes within pharmacy have affected their influence over the sales of RX and OTC medicines in this whitepaper....
Drivers of 2014′s Soaring Drug Approvals
The FDA & EMA approved a chart-topping number of new drugs in 2014. Read more in our White Paper about the responsibility this growing approval success will put on future...